Equasens
43.90
23-12月-24 08:05:57
15 分の遅延
株式
+0.85
+1.97%
本日の幅
43.00 - 43.90
ISIN
FR0012882389
ソース
Cboe
-
Equasens: 2024 nine-month revenue: €158.2 million - Return to growth in Q3 (+0.3%)
07 11 2024 12:00:00 提供 Nasdaq GlobeNewswire
-
Equasens: 2024 half-year results
27 9 2024 12:00:00 提供 Nasdaq GlobeNewswire
-
02 8 2024 12:00:00 提供 Nasdaq GlobeNewswire
-
05 7 2024 12:00:00 提供 Nasdaq GlobeNewswire
-
10 6 2024 12:00:23 提供 Nasdaq GlobeNewswire
-
07 5 2024 12:00:00 提供 Nasdaq GlobeNewswire
-
29 3 2024 13:02:37 提供 Nasdaq GlobeNewswire
-
Equasens: 2023 revenue: €219.7m, +2.6%
06 2 2024 12:00:00 提供 Nasdaq GlobeNewswire
-
Equasens: Acquisition of a majority stake in DIGIPHARMACIE
02 1 2024 12:00:00 提供 Nasdaq GlobeNewswire
-
Equasens: Changes in the Equasens Group Executive Committee
27 12 2023 12:00:00 提供 Nasdaq GlobeNewswire
-
EQUASENS: Acquisition of the German company ADV and creation of PHARMAGEST Germany
23 11 2023 12:00:00 提供 Nasdaq GlobeNewswire
-
09 11 2023 12:00:00 提供 Nasdaq GlobeNewswire
-
29 9 2023 12:00:00 提供 Nasdaq GlobeNewswire
-
EQUASENS GROUP: H1 2023 revenue: up 9% to €112.62m
03 8 2023 12:00:00 提供 Nasdaq GlobeNewswire
-
05 7 2023 12:00:00 提供 Nasdaq GlobeNewswire
-
09 6 2023 12:00:00 提供 Nasdaq GlobeNewswire
-
EQUASENS: Q1 2023 revenue: +13.96% to €56.25m
11 5 2023 12:00:00 提供 Nasdaq GlobeNewswire
-
EQUASENS: 2022 Net Profit: +18.35% to €48.70m
24 3 2023 13:00:00 提供 Nasdaq GlobeNewswire
-
EQUASENS: FY 2022 revenue: +10.88% to €214.07m
03 2 2023 12:00:00 提供 Nasdaq GlobeNewswire
-
EQUASENS: H2 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH GILBERT DUPONT
20 1 2023 12:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >